REG1VRevenio Group Oyj
13.96EUR+3.41%Mkt Cap: 353.85M EURP/E: 22.54Last update: 2026-05-29

Revenio Group Oyj, provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally. The company of…

Indicators:|

Key Statistics

Company
Market Cap353.85M EUR
Enterprise Value370.38M EUR
Revenue (TTM)111.05M EUR
Gross Profit77.80M EUR
Net Income (TTM)17.41M EUR
Revenue/Share4.158 EUR
Last Price13.96 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees246
CountryFI
SectorHealthcare
IndustryMedical Devices
ISINFI0009010912
Valuation
P/E (Trailing)22.54
P/E (Forward)14.44
PEG6.37
EV/EBITDA15.43
EV/Revenue3.34
P/S3.36
P/B3.25
EPS (TTM)0.59
EPS (Forward)0.97
52W Range
13.264% of range29.45
52W High29.45 EUR
52W Low13.26 EUR
Profitability
Gross Margin70.94%
Oper. Margin8.43%
EBITDA Margin21.61%
Profit Margin15.88%
ROE15.18%
ROA11.56%
Growth
Revenue Growth4.60%
Earnings Growth-41.40%
Cash Flow & Leverage
Operating CF30.23M EUR
CapEx (TTM)4.18M EUR
FCF Margin12.47%
FCF Yield3.91%
Net Debt-10.60M EUR
Net Debt/EBITDA-0.44
Balance Sheet
Debt/Equity0.10
Current Ratio2.27
Quick Ratio1.76
Book Value/Sh4.312 EUR
Cash/Share0.7880 EUR
Dividends
Fwd Div Rate0.4000 EUR
Trail. Div Rate0.4400 EUR
Div. Yield2.04%
5Y Avg Yield1.21%
Payout Ratio67.85%
Ex-Div DateApr 11, 2025
Pay Date
Splits
Last Split2:1
Split DateMar 20, 2020
Analyst Consensus
Rating
Target (Mean)19.38 EUR
Target Range15.00 EUR23.50 EUR
# Analysts4
Ownership
Shares Out.26.61M
Float26.72M
Insiders3.23%
Institutions60.79%
Technical
SMA 5016.21 (-13.9%)
SMA 20020.64 (-32.4%)
Beta0.85
S&P 52W Chg27.94%
Avg Vol (30d)86.27K
Avg Vol (10d)40.03K
Technical Indicators
RSI (14)31.9
MACD-0.6472
MACD Signal-0.7834
MACD Hist.+0.1362
BB Upper14.29 EUR
BB Middle13.85 EUR
BB Lower13.40 EUR
BB Width6.38%
ATR (14)0.4903 EUR
Vol Ratio (20d)1.70x